Cannabidiol , synthetic form (DrugBank: Cannabidiol)
19 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
2 | 筋萎縮性側索硬化症 | 0 |
6 | パーキンソン病 | 0 |
8 | ハンチントン病 | 0 |
13 | 多発性硬化症/視神経脊髄炎 | 0 |
36 | 表皮水疱症 | 0 |
46 | 悪性関節リウマチ | 0 |
95 | 自己免疫性肝炎 | 0 |
96 | クローン病 | 1 |
97 | 潰瘍性大腸炎 | 0 |
140 | ドラベ症候群 | 0 |
144 | レノックス・ガストー症候群 | 0 |
145 | ウエスト症候群 | 0 |
156 | レット症候群 | 0 |
157 | スタージ・ウェーバー症候群 | 0 |
158 | 結節性硬化症 | 0 |
193 | プラダー・ウィリ症候群 | 0 |
206 | 脆弱X症候群 | 0 |
226 | 間質性膀胱炎(ハンナ型) | 0 |
271 | 強直性脊椎炎 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04056442 (ClinicalTrials.gov) | July 7, 2019 | 13/8/2019 | A Phase 2a Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol as a Steroid-sparing Therapy in Steroid-dependent Crohn's Disease Patients | A Phase 2a, Randomized, Double-blind, Placebo-controlled, Crossover, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol (CBD) as a Steroid-sparing Therapy in Steroid-dependent Crohn's Disease Patients | Steroid Dependent Crohn's Disease | Drug: Cannabidiol , synthetic form;Drug: Placebo | Stero Biotechs Ltd. | NULL | Recruiting | 18 Years | N/A | All | 28 | Phase 2 | Israel |